Aegerion Pharmaceuticals, Inc. Contracts & Agreements

SUPPLEMENTAL INDENTURE (Filed With SEC on November 29, 2016)

SIXTH AMENDMENT TO FORBEARANCE AGREEMENT (Filed With SEC on November 4, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on November 4, 2016)

FIFTH AMENDMENT TO LEASE (Filed With SEC on November 4, 2016)

Annual Retainer (Filed With SEC on August 9, 2016)

AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on May 16, 2016)

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on May 16, 2016)

[Remainder of this page left intentionally blank.] (Filed With SEC on May 16, 2016)

[Remainder of this page left intentionally blank] (Filed With SEC on March 15, 2016)

[Remainder of this page left intentionally blank.] (Filed With SEC on March 15, 2016)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on March 15, 2016)

Mark Sumeray Temporary Assignment Plan (Filed With SEC on March 15, 2016)

Background (Filed With SEC on March 15, 2016)

FIRST AMENDMENT TO FORBEARANCE AGREEMENT (Filed With SEC on March 15, 2016)

SECOND AMENDMENT TO FORBEARANCE AGREEMENT (Filed With SEC on March 15, 2016)

THIRD AMENDMENT TO FORBEARANCE AGREEMENT (Filed With SEC on March 15, 2016)

AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 15, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on January 11, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2015)

AMENDED AND RESTATED INDUCEMENT AWARD STOCK OPTION PLAN SECTION1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS (Filed With SEC on September 23, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on August 17, 2015)

SIXTH LOAN MODIFICATION AGREEMENT (Filed With SEC on August 17, 2015)

AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on May 8, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2015)

THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [*] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on March 2, 2015)

FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (Filed With SEC on March 2, 2015)

THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [*] AND HAS BEENFILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on March 2, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on October 17, 2014)

JPMorgan Chase Bank,National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240... (Filed With SEC on August 21, 2014)

JPMorganChase Bank, National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240... (Filed With SEC on August 21, 2014)

AEGERION PHARMACEUTICALS, INC. 2.00% CONVERTIBLE SENIOR NOTES DUE 2019 INDENTURE DATED AS OF AUGUST 15, 2014 THE BANK OF NEWYORK MELLON TRUST COMPANY, N.A., AS TRUSTEE TABLE OF... (Filed With SEC on August 15, 2014)

$300,000,000 AegerionPharmaceuticals, Inc. 2.0% Convertible Senior Notes due 2019 PURCHASE AGREEMENT (Filed With SEC on August 12, 2014)

JPMorgan Chase Bank,National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240... (Filed With SEC on August 12, 2014)

JPMorgan Chase Bank, NationalAssociation Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240... (Filed With SEC on August 12, 2014)

FOURTH LOAN MODIFICATION AGREEMENT (Filed With SEC on May 9, 2014)

SECOND LOAN MODIFICATION AGREEMENT (Filed With SEC on March 3, 2014)

CONSENT AND THIRD LOAN MODIFICATION AGREEMENT (Filed With SEC on March 3, 2014)

FOURTH AMENDMENT TO LEASE (Filed With SEC on March 3, 2014)

INCENTIVE STOCK OPTION AGREEMENT UNDER THE AEGERION PHARMACEUTICALS, INC. 2010 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on March 3, 2014)

THIRD AMENDMENT TO LEASE (Filed With SEC on August 9, 2013)

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2013)

AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on August 9, 2013)

INCENTIVE STOCK OPTION AGREEMENT UNDER THE AEGERION PHARMACEUTICALS, INC. 2010 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on March 18, 2013)

AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 18, 2013)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on March 18, 2013)

AMENDMENT AND CONSENT AGREEMENT (Filed With SEC on February 21, 2013)

2,704,739 Shares Aegerion Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 14, 2013)

SECOND AMENDMENT TO LEASE (Filed With SEC on November 9, 2012)

FIRST LOAN MODIFICATION AGREEMENT (Filed With SEC on November 9, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2012)

3,400,000 Shares Aegerion Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 15, 2012)

AEGERION PHARMACEUTICALS, INC. LONG TERM INCENTIVE PROGRAMUNDER 2010 STOCK OPTION AND INCENTIVE PLAN Description of process for participant selection and determiningincentive... (Filed With SEC on May 10, 2012)

LOAN AND SECURITY AGREEMENT (Filed With SEC on March 29, 2012)

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 15, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on March 15, 2012)

This general releaseincludes, without limitation, any and all Claims arising out of or in connection with: (Filed With SEC on March 15, 2012)

FIRST AMENDMENT TO LEASE (Filed With SEC on March 15, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2011)

AMENDEMENT NO.l TO EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2011)

[ ] Shares Aegerion Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 20, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on May 16, 2011)

LOAN AND SECURITY AGREEMENT (Filed With SEC on March 4, 2011)

LEASE RREEF AMERICA REIT II CORP. PPP, Landlord, and AEGERION PHARMACEUTICALS, INC., Tenant Riverfront Office Park Cambridge, Massachusetts TABLE OF CONTENTS (Filed With SEC on January 6, 2011)

AEGERION PHARMACEUTICALS, INC. (a Delaware corporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 7, 2010)

FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.001 EACH, OF THE COMMON STOCK OF AEGERION PHARMACEUTICALS, INC. (Filed With SEC on October 7, 2010)

AEGERION PHARMACEUTICALS, INC. 2006 STOCK OPTION AND GRANT PLAN (Filed With SEC on October 7, 2010)

AEGERION PHARMACEUTICALS, INC. 2010 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on October 7, 2010)

EMPLOYMENT AGREEMENT (Filed With SEC on October 7, 2010)

LICENSE AGREEMENT (Filed With SEC on October 7, 2010)

LOAN AND SECURITY AGREEMENT (Filed With SEC on October 7, 2010)

AEGERION PHARMACEUTICALS, INC. FOURTH AMENDEDAND RESTATED NOTE PURCHASE AGREEMENT October 1,2010 AEGERION PHARMACEUTICALS, INC. FOURTH AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (Filed With SEC on October 7, 2010)

AEGERION PHARMACEUTICALS, INC. SENIOR SUBORDINATED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 7, 2010)

EMPLOYMENT AGREEMENT (Filed With SEC on October 7, 2010)

INDEMNIFICATION AGREEMENT (Filed With SEC on September 17, 2010)

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on September 17, 2010)

EMPLOYMENT AGREEMENT (Filed With SEC on September 17, 2010)

[Aegerion Pharmaceuticals, Inc.s Letterhead] (Filed With SEC on September 17, 2010)

AEGERION PHARMACEUTICALS, INC. 2006 STOCK OPTION AND GRANT PLAN (Filed With SEC on August 10, 2010)

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 10, 2010)

UNIVERSITY of PENNSYLVANIA PATENT LICENSE AGREEMENT (Filed With SEC on August 10, 2010)

LICENSE AGREEMENT (Filed With SEC on August 10, 2010)

SUBLEASE AGREEMENT (Filed With SEC on August 10, 2010)

LOAN AND SECURITY AGREEMENT (Filed With SEC on August 10, 2010)

SECURED PROMISSORY NOTE (Filed With SEC on August 10, 2010)

AMENDED AND RESTATED WARRANT AGREEMENT To Purchase Shares of the Series A Preferred Stock of Aegerion Pharmaceuticals, Inc. Dated as of September 29, 2008 (the Effective Date) (Filed With SEC on August 10, 2010)

AEGERION PHARMACEUTICALS, INC. THIRD AMENDEDAND RESTATED NOTE PURCHASE AGREEMENT June 14,2010 AEGERION PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (Filed With SEC on August 10, 2010)

AEGERION PHARMACEUTICALS, INC. SENIOR SUBORDINATED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 10, 2010)

FULLYPAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.001 EACH, OF THE COMMON STOCK OF AEGERION PHARMACEUTICALS, INC. (Filed With SEC on November 20, 2007)

AEGERION PHARMACEUTICALS, INC. 2006 STOCK OPTION AND GRANT PLAN (Filed With SEC on November 20, 2007)

2007 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on November 20, 2007)

EMPLOYMENT AGREEMENT (Filed With SEC on November 20, 2007)

Exhibit A BUSINESS PROTECTION AGREEMENT (Filed With SEC on November 20, 2007)

Exhibit A Business Protection Agreement BUSINESS PROTECTION AGREEMENT (Filed With SEC on November 20, 2007)

RESTRICTED STOCK PURCHASE AGREEMENT (Filed With SEC on November 20, 2007)

CONSULTING AGREEMENT (Filed With SEC on November 20, 2007)

AMENDED AND RESTATED CONSULTING AGREEMENT (Filed With SEC on November 20, 2007)

PATENT LICENSE AGREEMENT (Filed With SEC on November 20, 2007)

SUBLEASE AGREEMENT (Filed With SEC on November 20, 2007)

LOAN AND SECURITY AGREEMENT (Filed With SEC on November 20, 2007)

SECURED PROMISSORY NOTE (Filed With SEC on November 20, 2007)

WARRANT AGREEMENT To PurchaseShares of the Series A Preferred Stock of Aegerion Pharmaceuticals, Inc. Dated as of March 20, 2007 (the Effective Date) (Filed With SEC on November 20, 2007)

INDEMNIFICATION AGREEMENT (Filed With SEC on November 20, 2007)

2007 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on November 20, 2007)

AEGERION PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on November 20, 2007)

5,000,000 AEGERION PHARMACEUTICALS, INC. (Filed With SEC on May 25, 2007)

FULLYPAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.001 EACH, OF THE COMMON STOCK OF AEGERION PHARMACEUTICALS, INC. (Filed With SEC on May 25, 2007)

2007 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on May 25, 2007)

INVESTOR RIGHTS AGREEMENT (Filed With SEC on May 25, 2007)

CONSULTING AGREEMENT (Filed With SEC on May 25, 2007)

AMENDED AND RESTATED CONSULTING AGREEMENT (Filed With SEC on May 25, 2007)

PATENT LICENSE AGREEMENT (Filed With SEC on May 25, 2007)

2007 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 25, 2007)

AEGERION PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on May 25, 2007)

INDEMNIFICATION AGREEMENT (Filed With SEC on May 4, 2007)

EMPLOYMENT AGREEMENT (Filed With SEC on April 10, 2007)

PATENT LICENSE AGREEMENT (Filed With SEC on April 10, 2007)

LOAN AND SECURITY AGREEMENT (Filed With SEC on April 10, 2007)

SECURED PROMISSORY NOTE (Filed With SEC on April 10, 2007)

WARRANT AGREEMENT To PurchaseShares of the Series A Preferred Stock of Aegerion Pharmaceuticals, Inc. Dated as of March 20, 2007 (the Effective Date) (Filed With SEC on April 10, 2007)

AEGERION PHARMACEUTICALS, INC. 2006 STOCK OPTION AND GRANT PLAN (Filed With SEC on March 21, 2007)

RESTRICTED STOCK PURCHASE AGREEMENT (Filed With SEC on March 21, 2007)

CONSULTING AGREEMENT (Filed With SEC on March 21, 2007)

AMENDED AND RESTATED CONSULTING AGREEMENT (Filed With SEC on March 21, 2007)

SUBLEASE AGREEMENT (Filed With SEC on March 21, 2007)

Category

Industry

Companies

Contracts

Aegerion Pharmaceuticals, Inc. Contracts & Agreements